BridgeMD
New treatment option for Chronic Low-back Pain (cLBP)
Official title Treatment Validation for Myofascial Pain
ClinicalTrials.gov ID: NCT07133139
What this study is testing
- What it's testing
- The goal of this clinical trial is to see if a body test called the NUN biomarker can track changes in chronic low back pain after dry needling and predict who will feel better. This study is for adults with chronic low back pain from muscle pain (Myofacial Pain).
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Ages 20-70;
- Predominantly axial LBP (meeting NIH definition of cLBP with daily pain for at least 3 months) with a MP component as determined by the standardized...
- Average pain score of \> 3/10, with low back pain being the primary pain site;
- CLBP meeting Quebec Task Force Classification System categories I-III (from axial pain only to pain radiating beyond the knee without neurological...
- NO HISTORY of receiving dry needling, to improve the how well it works of the blind;
You likely can't join if
- Back surgery within the past six months;
- Active workers' compensation or litigation claims, since these patients are more likely to have exaggerated pain behavior;
- New pain treatments within 2 weeks of enrollment;
- Any clinically unstable systemic illness or condition that is judged to interfere with the trial;
- Non-ambulatory status;
- Not able to complete the questionnaire
See the full eligibility criteria
- Ages 20-70;
- Predominantly axial LBP (meeting NIH definition of cLBP with daily pain for at least 3 months) with a MP component as determined by the standardized examination for MP;
- Average pain score of \> 3/10, with low back pain being the primary pain site;
- CLBP meeting Quebec Task Force Classification System categories I-III (from axial pain only to pain radiating beyond the knee without neurological signs). Constant radicular pain associated with sensory loss is likely a...
- NO HISTORY of receiving dry needling, to improve the how well it works of the blind;
- Demonstration of healthcare seeking at some point for LBP.
- Back surgery within the past six months;
- Active workers' compensation or litigation claims, since these patients are more likely to have exaggerated pain behavior;
- New pain treatments within 2 weeks of enrollment;
- Any clinically unstable systemic illness or condition that is judged to interfere with the trial;
- Non-ambulatory status;
- Not able to complete the questionnaire
- Currently pregnant or have intentions to become pregnant during the study.
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.